BIO Nha Trang Vaccines And Biological Products JointStock Co
Distress ·
Bio-Rad Laboratories said on August 4, 2026 that the plan includes position eliminations and facility closures worldwide and is expected to be substantially completed by the end of fiscal year 2027. Second-quarter net sales were $651.0 million.
Bio-Rad began the plan on February 7, 2025 and expects it to be substantially completed by the end of fiscal 2025. The company also made a binding offer to buy Stilla Technologies.
Nha Trang Vaccines And Biological Products JointStock Co trades under the ticker BIO on UPCOM.
Nha Trang Vaccines And Biological Products JointStock Co is listed on UPCOM.
Our directory records Nha Trang Vaccines And Biological Products JointStock Co under Vietnam.
Our directory classifies Nha Trang Vaccines And Biological Products JointStock Co as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
The ISIN recorded for Nha Trang Vaccines And Biological Products JointStock Co is VN000000BIO6.
aibio.space lists Nha Trang Vaccines And Biological Products JointStock Co among 2,820 public biotech companies and publishes its news here as stories appear.
Our latest story on Nha Trang Vaccines And Biological Products JointStock Co, dated Aug 4, 2026: "Bio-Rad starts restructuring plan with $80 to $90 million in pre-tax charges". Bio-Rad Laboratories said on August 4, 2026 that the plan includes position eliminations and facility closures worldwide and is expected to be substantially completed by the end of fiscal year 2027. Second-quarter net sales were $651.0 million. Source.
Our latest distress story, dated Aug 4, 2026: "Bio-Rad starts restructuring plan with $80 to $90 million in pre-tax charges". Bio-Rad Laboratories said on August 4, 2026 that the plan includes position eliminations and facility closures worldwide and is expected to be substantially completed by the end of fiscal year 2027. Second-quarter net sales were $651.0 million. Source.
Companies in our directory listed in the same country and business area as Nha Trang Vaccines And Biological Products JointStock Co: Ben Tre Pharmaceutical JSC, Central Pharmaceutical CPC1.JSC, Mekophar Chemical Pharmaceutical Joint Stock, Domesco Medical Import-Export JSC, Ha Noi Pharma Joint Stock Co, National Day Pharmaceutical Joint Stock Co.
Press Follow on this page to add Nha Trang Vaccines And Biological Products JointStock Co to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming Nha Trang Vaccines And Biological Products JointStock Co so far, in Distress.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio